All Curated Mutation Sites in HCV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HCV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
5'UTR
  
C
  
E1
  
E2
  
NS2
  
NS3
  
NS4B
  
NS5A
  
NS5B
  
p7
  
Protease
  

Keyword: HCV Infection-32275694
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 32275694 V55A
NS3
NS3
HCV Infection
D
G
R
S
C
L
View
2 32275694 V55D
NS3
NS3
HCV Infection
D
G
R
S
C
L
View
3 32275694 S122G
NS3
NS3
HCV Infection
D
G
R
S
C
L
View
4 32275694 R155K
NS3
NS3
HCV Infection
D
G
R
S
C
L
View
5 32275694 R155T
NS3
NS3
HCV Infection
D
G
R
S
C
L
View
6 32275694 R155I
NS3
NS3
HCV Infection
D
G
R
S
C
L
View
7 32275694 D168T
NS3
NS3
HCV Infection
D
G
R
S
C
L
View
8 32275694 Q80R
NS3
NS3
HCV Infection
G
R
S
C
L
View
9 32275694 V36A
NS3
NS3
HCV Infection
D
G
R
S
C
L
View
10 32275694 V36G
NS3
NS3
HCV Infection
D
G
R
S
C
L
View
11 32275694 Q80K
NS3
NS3
HCV Infection
G
R
S
C
L
View
12 32275694 V36L
NS3
NS3
HCV Infection
D
G
R
S
C
L
View
13 32275694 T54S
NS3
NS3
HCV Infection
D
G
R
S
C
L
View
14 32275694 V55I
NS3
NS3
HCV Infection
D
G
R
S
C
L
View
15 32275694 D168Q
NS3
NS3
HCV Infection
D
G
R
S
C
L
View
16 32275694 V158I
NS3
NS3
HCV Infection
D
G
R
S
C
L
View
17 32275694 I170V
NS3
NS3
HCV Infection
D
G
R
S
C
L
View
18 32275694 S122T
NS3
NS3
HCV Infection
G
R
S
C
L
View
19 32275694 S122R
NS3
NS3
HCV Infection
G
R
S
C
L
View
Contents
Description

The table shows all curated mutation sites of HCV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.